Saudi Arabia Grants World’s First Approval for Iberdomide in Multiple Myeloma | iPharmaCenter (ipharmacenter.com)
The Saudi Food and Drug Authority has become the first regulatory agency worldwide to approve iberdomide for adults with relapsed or refractory multiple myeloma.The treatment, marketed as ZENBEXUS, is...
URGENTE: A Arábia Saudita tornou-se o primeiro país a aprovar iberdomida com daratumumabe e dexametasona para adultos com mieloma múltiplo recidivado ou refratário.
www.ipharmacenter.com/post/saudi-a...